Neurobo Pharmaceuticals Stock Target Price and Analyst Consensus

NRBODelisted Stock  USD 2.36  0.01  0.43%   
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Neurobo Pharmaceuticals price targets

Neurobo Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Neurobo Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Neurobo Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Neurobo Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Neurobo Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Neurobo Pharmaceuticals is a key component of Neurobo Pharmaceuticals valuation and have some predictive power on the future returns of a Neurobo Pharmaceuticals.
Hype
Prediction
LowEstimatedHigh
0.112.257.07
Details
Intrinsic
Valuation
LowRealHigh
0.122.327.14
Details
Naive
Forecast
LowNextHigh
0.052.577.39
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.242.362.48
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neurobo Pharmaceuticals. Your research has to be compared to or analyzed against Neurobo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Neurobo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Neurobo Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Check out Macroaxis Advice on Neurobo Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Neurobo Stock

If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bonds Directory
Find actively traded corporate debentures issued by US companies